Your browser doesn't support javascript.
loading
Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention.
Fleming, Bryan D; Urban, Daniel J; Hall, Matthew D; Longerich, Thomas; Greten, Tim F; Pastan, Ira; Ho, Mitchell.
Affiliation
  • Fleming BD; Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD.
  • Urban DJ; NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, Rockville, MD.
  • Hall MD; NCATS Chemical Genomics Center, National Center for Advancing Translational Sciences, Rockville, MD.
  • Longerich T; Institute of Pathology, University Hospital, Heidelberg, Germany.
  • Greten TF; Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, Bethesda, MD.
  • Pastan I; Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD.
  • Ho M; Laboratory of Molecular Biology, National Cancer Institute, Bethesda, MD.
Hepatology ; 71(5): 1696-1711, 2020 05.
Article in En | MEDLINE | ID: mdl-31520528

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Immunotoxins / ADP Ribose Transferases / Carcinoma, Hepatocellular / Virulence Factors / Exotoxins / Glypicans / Single-Domain Antibodies / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Hepatology Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Immunotoxins / ADP Ribose Transferases / Carcinoma, Hepatocellular / Virulence Factors / Exotoxins / Glypicans / Single-Domain Antibodies / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Hepatology Year: 2020 Document type: Article Affiliation country: